The role of the introduction of digital production systems in a pharmaceutical enterprise

Due to the growing global crisis against the background of the COVID-19 pandemic, the issue of uninterrupted provision of medicines to the population has become critically important. In this regard, the introduction of information management systems at pharmaceutical enterprises is becoming particularly relevant. The pharmaceutical industry as a whole faces a number of unique challenges, including close regulatory oversight, sophisticated testing methods, and growing financial pressures as competition in the market increases. Industry leaders are digitizing core functions within their internal vertical operational processes, as well as with their value chain partners. One of the information management systems in the laboratory is the LIMS (Laboratory information system) information system. One of the challenges when choosing LIMS in pharmaceuticals is the variety of laboratories in the company - combinatorial chemistry, screening, preclinical and clinical bioanalysis, analytical chemistry, industrial R&D and production quality control, requiring unique needs and workflows. With the development of business, information technology and the regulatory framework, the role of LIMS in the pharmaceutical organization is also increasing. Proper implementation of this mechanism in the work of a pharmaceutical enterprise will help to preserve the quality of the product, reduce and optimize the work and satisfy the end user and government agencies.